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Abstract:  
Despite increased efforts over the last decade to prospectively identify individuals at ultra-
high risk of developing a psychotic illness, limited attention has been specifically directed 
towards adolescent populations (<18 years). In order to evaluate how those under 18 
fulfilling the operationalised criteria for an At-Risk Mental State (ARMS) present and fare 
over time, we conducted an observational study. Participants (N=30) generally reported a 
high degree of functional disability and frequent and distressing perceptual disturbance, 
mainly in the form of auditory hallucinations. Seventy percent (21/30) were found to fulfil 
the criteria for a co-morbid ICD-10 listed mental health disorder, with mood (affective; 
13/30) disorders being most prevalent. Overall transition rates to psychosis were low at 24 
month follow-up (2/28; 7.1%) whilst many participants demonstrated a significant reduction 
in psychotic-like symptoms. The generalisation of these findings may be limited due to the 
small sample size and require replication in a larger sample. 
 
Keywords: psychosis, risk, youth, prodrome 
 
Abbreviations: ARMS (At-Risk Mental State for psychosis) 
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Introduction  
Schizophrenia-spectrum disorders are usually preceded by a prodromal period characterised 
by changes in thinking, perception, mood, affect and behaviour [1]. Efforts have been made 
to prospectively identify a state of increased risk for impending illness [2]. As this state is 
conceptualised as conferring a relatively increased, but not inevitable risk of illness it has 
been labelled as an ‘At-Risk Mental State’ (ARMS) for psychosis (compared to the  
retrospectively recognised ‘prodrome’). This ARMS or ‘psychosis risk syndrome’ 
(predominately defined by the presence of one or more attenuated psychotic symptoms, 
occurring within the last year, leading to distress and help seeking), was proposed for 
inclusion in the upcoming DSM-V [3,4]. Potential benefits of this new diagnostic criteria 
have been highlighted [5]. However, critics of the concept argued that this diagnostic 
category is premature given the relatively low positive predictive value and the, as yet, 
unquantified risks of identifying ‘false positive’ cases [6,7]. Consequently the DSM working 
group have decided against inclusion of such a syndrome in DSM-V [8].  
 
Within the ARMS literature, research focussing specifically on younger adolescents (<18 
years) as opposed to adults and older adolescents (≥18 years) is scarce. However, 
identification of the ARMS in this age group should be considered a high stakes issue since 
young people who go on to develop psychosis generally experience worse outcomes [9,10] 
and describe more severe symptomatology in the form of ‘negative’ symptoms [11,12]. 
Moreover, possible signs and symptoms of the ARMS in this age group lack specificity [1] 
and may represent neuro-maturational and psychological changes occurring naturally during 
adolescence [13,14]. Subclinical psychotic symptoms also appear transitory in children [15] 
and adolescents [16] and are frequently reported by non-help seeking adolescent populations 
[17-19] although the latter is also the case in adults [20].   
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‘Wrongful’ identification might expose young people to unnecessary labelling and potentially 
hazardous pharmacological treatments [21] and  use of a ‘psychosis’ related label could 
potentially obstruct a patient’s communicative interactions with others [22,23]. A better 
understanding of the presentation and characteristics of adolescents with a potential ARMS is 
thus crucial to informing the approach of mental health services to affected individuals.  
 
Prospective studies of adults with an ARMS indicate that individuals present with substantial 
impairments in functioning, symptomatology and quality of life [24-28]. The majority of 
these individuals report distressing attenuated symptoms of perceptual disturbances and 
ideational anomalies [29-31]. Several studies report that a high proportion of those identified 
with an ARMS also fulfil the criteria for another Axis I mental health diagnosis, mostly 
relating to mood, anxiety and substance misuse [24,26,27]. Additionally, around 10% of 
ARMS individuals have attempted suicide shortly before presentation [32]. In terms of 
transition rates to psychosis a recent meta-analysis (mean age 19.9 years) estimated  around 
18% of such individuals develop psychosis by six months, reaching 36% after three years 
[33] with existing data suggesting  transition is most likely within the first six months after 
identification [34].   
 
Only a handful of studies have looked at the presentation of at-risk adolescents [35-38] 
excluding studies where risk is solely based on genetic predisposition. In one of the first 
studies, Meyer and colleagues [36] identified 24 adolescents who reported significant 
perceptual abnormalities (20/24, 83%), unusual thought content (18/24, 75%) and 
suspiciousness (13/54%) symptoms at baseline assessment. Twelve (50%) participants also 
met DSM-IV criteria for a major depressive disorder. Other co-morbidities observed included 
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social phobia, generalised anxiety, post-traumatic stress and eating disorders. The authors 
concluded that identifying adolescents with a potential ARMS is challenging given that the 
majority of participants met actual and sub-threshold criteria for around 3-4 mental disorders. 
In one of the largest studies to date Ziermans and colleagues [38] assessed 72 adolescents and 
discovered that the vast majority presented with impaired functioning (Mean GAF= 59.6), 
some form of attenuated psychotic symptoms (90.3%), but few reported a history of regular 
cannabis abuse (around 20%).  
 
In terms of transition to psychosis, two adolescent-specific cohorts report transition rates of 
14% and 15.6% after 18 and 24 months respectively [39,38]. The latter study also reported 
that 50% of participants experienced a full remission of symptoms within the outlined two 
year period. These findings have subsequently been confirmed in a separate study where full 
remission of subclinical hallucinations was apparent in 50% of participants whilst partial 
remission was observed in two-thirds of the 84 strong cohort [16]. A separate study reported 
that those who experience attenuated psychotic symptoms prior to 18 years are significantly 
more likely to subsequently develop psychosis [40], suggesting that studies investigating 
transition to psychosis should consider oversampling adolescents.  
 
The majority of ‘at-risk’ studies have recruited adolescents from adult-orientated trials or 
retrospective patient data. Thus there has been little focus on individuals drawn from 
Community Child and Adolescent Mental Health Services (CAMHS). Recently published 
UK guidelines from the National Institute for Health and Clinical Excellence (NICE) in 
relation to the recognition and management of psychosis in children and young people [41], 
also highlights research in this age group as a priority area. The primary aim of the present 
study was to clinically characterise adolescents (<18 years), identified as having an ARMS, 
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presenting to CAMHS. A secondary aim was to report six, twelve and twenty four month 
outcomes in terms of transition rates and symptom levels.  
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Methods 
 
Participants 
A research clinic (the ‘Follow-up of the At-Risk Mental State for Psychosis’ - FARMS 
Clinic) was established (for the purposes of this study). This was hosted within an NHS Early 
Intervention in Psychosis (EIP) service in North-East England. The service serves an 
adolescent population of around 150,000 people living across a mix of rural and urban 
communities. The remit of the clinic was to assess adolescents fulfilling the ARMS criteria. 
Referrals to the clinic were only accepted from CAMHS clinicians after an initial telephone 
consultation with one of the research team. CAMHS clinicians were only asked to contact the 
clinic if a set of screening criteria were met (see Online Resource 1). Referrals were accepted 
if the young person was; under the care of CAMHS services; aged between 12 to 18 years of 
age, and; suspected of fulfilling the ARMS criteria (based upon the information supplied 
during the consultation). This screening process was utilised to ensure that the majority of 
accepted referrals would meet ARMS criteria upon further assessment as a means of 
effectively managing clinical time. Potential participants were excluded from study entry if 
they had a significant learning disability (IQ<70). Individuals became eligible for study 
inclusion after conducting a full clinical assessment at the FARMS clinic. Individuals 
subsequently identified as having an ARMS as defined by the Melbourne Ultra High risk 
criteria [34; see Table 1] were approached and consent sought. Subsequent care and support 
for those identified was provided by local CAMHS and EIP services as required.     
 
Baseline Assessment Measures 
All individuals accepted for initial assessment by the FARMS Clinic were asked to complete 
a battery of assessments. Assessment measures were administered by either or both 
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researchers (PW and PAT).  
 
The Comprehensive Assessment of At-Risk Mental States (CAARMS) is a semi-structured 
interview designed specifically for the assessment of help seeking individuals suspected of 
having ARMS [42]. It measures a range of ‘positive’ psychotic like symptoms and 
categorises individuals using the Melbourne UHR into three potential groups (See Table 1). 
Group 1 (Vulnerability Group) represents individuals who have a first degree family history 
of psychosis. Group 2 (Attenuated Psychosis Group) represents individuals with either sub-
threshold psychotic like symptoms based upon their lower intensity and/or frequency. Group 
3 (BLIPS Group) represents individuals experiencing intense and frequent psychotic 
symptoms which last no longer than a week in duration and spontaneously remitted. For all 
groups symptoms have to be associated with a period of declining or chronically poor 
functioning. Acceptable levels of inter-rater reliability between both researchers in scoring 
the CAARMS was demonstrated (κ= 0.75). During assessment, deterioration or chronic 
functioning was estimated using the Children’s Global Assessment Scale (C-GAS; [43]).   
 
In order to assess for current co-morbidity the Development and Well-Being Assessment 
(DAWBA) was utilised to generate ICD-10 psychiatric diagnoses [44]. Information was 
collected from several sources where possible, using direct observations and information 
from the young person, their medical notes as well as parental and/or teacher reports. To 
ensure a rigorous methodological approach to diagnosis, principles of the best estimate 
procedure were adopted [45] whereby both researchers were kept blind as to each other’s 
decisions until a diagnostic review meeting was undertaken (also involving the young person 
treating clinician). Diagnostic decisions and confirmation of an ARMS were made via 
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consensus between all group members.  
 
Other assessment tools utilised in order to improve diagnostic categorisation and record 
symptom profiles included the Young Mania Rating Scale [46] and Hamilton Depression 
Rating Scale (HAM-D; [47]). The Social & Communication Disorder Checklist was used as 
brief screening measure for pervasive developmental disorders [48].   
 
[Insert Table 1 here] 
 
Follow-up Assessment measures 
Where possible, individuals were assessed using the CAARMS and the C-GAS. Medical 
notes and information obtained from the young person’s treating clinician were also reviewed 
to assess for the possibility of psychosis transition, symptom and ARMS remission and to 
record interventions offered by CAMHS and EIP services within the intervening period. 
Psychosis transition was defined by CAARMS scores above the threshold stipulated for 
ARMS identification (Table 1) alongside the initiation of anti-psychotic medication. In 
addition, individual presentations had to fulfil the ICD-10 diagnostic criteria for 
schizophrenia or a related disorder (e.g. delusional disorder) in order to be deemed to have 
transitioned to psychosis. Thus, psychosis transition would be established via information 
from medical records and treating clinicians, and where possible, direct assessment via face-
to-face or telephone interview. 
 
Data Analysis  
Data analysis was predominately descriptive in nature although appropriate non-parametric 
statistical tests were employed to assess for significant differences between baseline and 
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follow-up assessment measures and other measures where required (e.g. Wilcoxon signed-
rank test, Chi square and Fisher’s exact tests).    
 
Ethics and ethical considerations 
Ethical approval for the study was granted by Durham University, School of Medicine and 
Health Ethics Committee and the NHS National Research Ethics Service for County Durham 
& Tees Valley. Informed written consent was obtained from all participants. In the case of 
younger adolescents (those below 14 years), consent was also obtained from a parent/carer. 
Consent was also taken in advance for permission to contact participants and review medical 
notes at the subsequent follow up stages. For individuals who went on to develop psychosis, 
the follow up assessment regimen was adjusted to accommodate for their present psychiatric 
condition. 
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Results 
 
Demographics 
Thirty-eight adolescents were assessed by the FARMS clinic between January 2010 and April 
2011, with 30 individuals identified as fulfilling the ARMS criteria and consenting to study 
participation. Of those not meeting intake criteria for the study; three were already psychotic 
at the time of the assessment, three disengaged halfway through the assessment process 
whilst two were deemed to be below the symptom threshold required for an ARMS. The 
mean age of the ARMS sample was 15.8 years (s.d. = 1.4) whilst the sex distribution was 
relatively even (Female=16/30, 53%). All participants were of a White British ethnic origin 
(which reflects the lack of ethnic diversity locally) and met the criteria for Group 2 
(Attenuated Psychosis Group) of the Melbourne UHR criteria. Of these, four individuals also 
had a family history of psychosis (Group 1; Vulnerability Group).  
 
‘Positive’ symptomatology  
The majority of participants presented with some form of auditory perceptual disturbances 
(27/30; 90%) although Bizarre ideas, Visual Changes and Suspiciousness/Persecutory Ideas 
were also commonly experienced. Ninety percent (27/30) of individuals reported co-
occurring perceptual disturbances alongside delusional ideation.      
 
Global rating, frequency and duration and associated distress scores for positive symptoms as 
measured by the CAARMS are outlined in Table 2. These suggest that Perceptual 
Abnormalities were the most intense and distressing symptoms experienced within the cohort 
whilst symptoms of Disorganised Speech indicate a picture of relatively low intensity and 
distress.  
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[Insert Table 2 here] 
 
ICD-10 co-morbid conditions  
In total 21/30 (70%) participants were found to meet the threshold for at least one current 
ICD-10 Axis I diagnoses. Individuals were most likely to meet the criteria for a depressive 
illness (13/30; 43%), anxiety disorders (6/30; 20%) or pervasive developmental disorders 
(5/30; 17%). The high levels of depressive illness are reflected in the mean overall HAM-D 
scores (10.9; s.d.=6.4) which indicate a mild severity considered to be outside the normal 
population range. Further analysis of depressed individuals, indicated that these participants 
were less likely to report Suspiciousness/Persecutory Ideas (χ2= 4.434, p= .035) but 
experienced more distressing symptoms of Unusual Thought Content (z= -2.18, p= .031) and 
Perceptual Abnormalities (z= -2.25, p= .025). The co-morbid data analysis also indicates that 
reported substance abuse (prior and current alcohol and illicit drug use) within the sample 
was low. Seven of the 30 participants (23%) were found to have two current co-morbid ICD-
10 Axis I diagnoses.  
 
[Insert Table 3 here] 
 
As well as meeting the threshold for an Axis I diagnosis many participants were recorded as 
experiencing sub-threshold difficulties. These were defined as symptoms that did not reach 
the threshold for an Axis I diagnosis using ICD-10. This was because they were deemed to be 
secondary to (and potentially caused by) the primary Axis I diagnosis or were not detrimental 
to the person’s functioning at that time. The most frequent of these sub-threshold symptoms 
appeared to be obsessive compulsive symptoms (10/30; 33%), depression (9/30; 30%) and 
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abnormally elevated or irritable mood (‘Mania’; 9/30; 30%). Also within this cohort, a high 
proportion of individuals reported having attempted suicide (9/30; 30%) or had engaged in 
significant self-harm (16/30; 53%) within the previous six month period. 
 
Six month outcomes 
It was possible to establish the current mental state for 29/30 (97%) participants at six 
months. Only one participant had become psychotic during the previous six months (1/29; 
3.4%). This individual was male, had experienced paranoid and multi-sensory perceptual 
experiences for a duration of at least one month prior to follow-up and was subsequently 
diagnosed with Schizophrenia, unspecified (ICD-10 code; F20.9). Seven of the remaining 
twenty-eight individuals no longer fulfilled criteria for an ARMS (7/28; 25%). In terms of 
symptomatology, there was a significant remission in the presence of Visual Changes (χ2= 
5.371, p= .02) and Disorganised Speech (χ2= 10.286, p= .01) as well as a significant 
improvement in C-GAS scores (z =-2.811, p =.005) at the six month stage. A list of 
interventions offered after identification indicates that participants received a variety of 
interventions for their psychotic-like symptoms.  
 
[Insert Table 4 here] 
 
Twelve and twenty-four month outcomes  
Due to the withdrawal of consent by two participants and the refusal of several participants to 
engage in follow-up CAARMS assessments, follow-up analysis mainly relied upon 
inspection of medical records and clinician information. Data indicated that 3/29 (10%) had 
been lost to follow-up at the twelve month stage making it impossible to establish their 
current mental state. At this time point, no further individuals had made the transition to 
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psychosis, although many remained in contact with mental health services (16/26; 62%), 
mainly due to reported depressive symptoms and/or sub-threshold psychotic symptoms 
(Table 5). At the twenty-four month stage, one participant originally lost to follow-up at the 
six and twelve month assessment points, returned to services due to admittance to an accident 
and emergency department as a result of an overdose. There was evidence from medical 
records that one additional participant had become psychotic. This assertion is based upon the 
reporting of persistent and distressing auditory and visual hallucinations by the participant to 
the treating clinician, as recorded in their medical notes. Moreover, treatment with an 
antipsychotic (quetiapine) was instigated specifically for these symptoms. It was clear from 
the psychiatric notes that the treating clinician considered these phenomena as indicative of a 
psychotic illness. This event took the overall observed transition rate in this cohort to 2/28 
(7.1%). However, some caution should be exercised in assuming this latter transition event as 
the participant had declined a face-to-face interview at this point in the follow-up. Thus direct 
assessment and verification of illness status was not possible.     
 
[Insert Table 5 here] 
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Discussion 
The findings indicate that adolescents with an ARMS present to mental health services with 
significant levels of impairment. These findings are comparable to those observed in other 
studies predominately consisting of older adolescents and adults [25,29-31]. In terms of 
symptomatology perceptual abnormalities, especially auditory hallucinations are the most 
frequent, distressing and severe ‘positive symptoms’ experienced by adolescents. These 
findings are supported by one other adolescent specific study [36] but not by those recruiting 
adult samples [30,25] who report more prevalent symptoms of suspiciousness and non-
bizarre ideas. It has been postulated that hallucinatory experience may give rise to secondary 
delusional interpretation, thus increasing the risk of psychosis transition [49]. For example, 
the mere experience of voices itself does not lead to full-blown psychotic symptoms, but 
attributing the voice to an external source and giving it personal significance does [50]. 
Despite this, in our sample there was virtually no early transition to psychosis evident. This is 
possibly because these auditory disturbances may have been more dissociative in nature, as 
opposed to being related to a psychotic illness. Such dissociative experiences are known to 
commonly occur in non-clinical samples of adolescents [51].   
 
In line with previous findings, co-morbidity at presentation to services was the norm, with 
depression and anxiety disorders frequently observed [24,26,35,36,27]. Interestingly, 
individuals with co-morbid depression experienced more perceptual disturbances and unusual 
thought content, suggesting the existence of a sub-group of ARMS individuals. In contrast, 
high rates of Pervasive Developmental Disorder are not reported by studies recruiting mainly 
working-age adults. This may reflect the ability of child and adolescent services to identify 
developmental disorders [52] or the reduction of detectable autistic symptoms with age and 
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maturation. Indeed within adolescent ARMS populations, PDD may be prevalent given its 
probable association with juvenile-onset schizophrenia [53].  
 
Our observed short-term transition rate of 3.4% and longer-term rate of 7.1% is low 
compared to those reported by a recent meta-analysis (18% at six month and 29 % at two 
years; [33]) and other adolescent studies published to date [38,39]. Thus, our findings do not 
support the view that adolescents are significantly more likely to make the transition to 
psychosis compared to older individuals [40]. The observed reductions in visual 
hallucinations, disorganised speech and improvements in psycho-social functioning at six 
months also indicate that adolescents may experience more transitory subclinical psychotic 
symptoms [16] compared to adults, making prediction of transitions to illness more 
challenging. Thus, this small sample of particpants may have included a significantly high 
number of ‘false positive’ cases (those who were never at risk of psychosis). Other 
explanations for these disparities include swift and effective access to treatments (due to the 
establishment of this assessment clinic) which ultimately delayed or prevented psychosis 
transition. In spite of the transitory nature of psychotic-like symptoms, many adolescents 
appear to remain in clinical contact with mental health services twelve month post 
identification, although this appears in order to receive on-going support for other difficulties 
such as depression, anxiety and self-harm.   
 
To the authors’ knowledge this is the first study to prospectively characterise and assess the 
short term outcomes of adolescents with an ARMS within the UK. Despite the ‘hard to reach’ 
nature in recruiting adolescent populations, the sample size of 30 individuals is small 
(especially in comparison to the recent EDIE-2 treatment trial; n=288 [25]) and was thus 
underpowered to robustly explore putative predictors of transition. Moreover, the small 
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numbers of participants and limited sampling frame (e.g. a section of NE England) limits the 
generalisability of these findings to other clinical populations. Future research should 
therefore adopt multi-site designs in order to validate our findings in this patient group. 
Larger samples may also permit statistical identification of symptom clusters in order to 
validate distinct sub-groups of patients, for example via latent class analysis. Understanding 
how this patient group differs to other adolescents psychiatric help-seekers, via a case-control 
study design, would be useful in comparing short to medium term clinical outcomes and 
symptom profiles. Moreover, an analysis of ‘positive’ symptom clusters across co-morbid 
conditions, the use of a validated screening tool (such as the PROD screen, [54]) at the 
telephone referral stage and the recording of previous treatment history would have improved 
the present study design.  
 
The varied symptom and co-morbidity profiles observed in adolescents, combined with 
potentially low transition rates and high levels of symptom remission may result in increased 
apprehension regarding the categorisation of younger adolescents as having an ARMS. 
Indeed, it has been postulated that at times psychotic-like symptoms may represent ‘clinical 
noise’ around a non-psychotic syndrome [55]. Regardless of this the high levels of distress 
and impairments our participants reported suggest that these individuals require some form of 
support from services. Treatment could target distressing symptoms and aim to improve 
psychosocial functioning. Indeed, these may be more of an issue than the risk of transition to 
psychosis [56]. In order to manage therapeutic resources and reduce any adverse effects of 
wrongful identification, it may be sensible to initially offer individuals the least invasive 
interventions possible (i.e. psycho-education, solution focussed therapy). Our data may 
indicate that individuals who do not experience symptom or functional remission from an 
ARMS after six months, should then be offered a more intensive form of psychological 
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intervention (i.e. CBT). Given our findings, a move away from measuring transition as a 
primary outcome and a focus upon symptom remission and functional improvement maybe 
sensible.  
 
Summary  
As in adults, young adolescents fulfilling the ARMS criteria present to mental health services 
with high levels of non-specific psychopathology, impaired functioning and distress.  
However, the low transition rate and high levels of symptom remission (even over a short 
term period) not only questions the validity of these criteria to predict future psychosis but 
may highlight a more fluctuating symptomatic state in this younger population. These 
putative differences should be taken into account when designing services for younger 
populations presenting with the clinical picture of an ARMS. 
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